Sakar Healthcare Ltd.
Snapshot View

185.70 -5.75 ▼-3.0%

05 August 2021, 03:46:28 P.M.
Volume: 88,951

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sakarhealthcare.com
Financial Indicators
Market Cap 317.88 Cr.
Earnings per share (EPS) 6.25 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 29.73 Trailing Twelve Months Ending 2021-03
Industry PE 32.75 Trailing Twelve Months Ending 2021-03
Book Value / Share 66.19 Trailing Twelve Months Ending 2021-03
Price to Book Value 2.81 Calculated using Price: 185.70
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 1.71 Cr. 17,118,000 Shares
FaceValue 10
Company Profile

Having a vision to make lives healthy, happy and more meaningful by providing healthcare solutions, Sakar Healthcare Limited, was incorporated on March 26, 2004. Subsequently, the company was converted into a public limited company and a fresh Certificate of Incorporation consequent upon change of name on Conversion to Public Limited Company dated March 27, 2015 was issued by the Registrar of Companies, Gujarat, Ahmedabad and the name of the company has got changed to 'Sakar Healthcare Limited'.

The company is managed by a team of professionals headed by its Managing Director having experience in manufacturing and export of pharmaceutical and health care products to various countries. Its preliminary business area and key focus was in contract manufacturing in the past years. As a contract manufacturer, the company undertakes manufacturing on behalf of some of the leading pharmaceutical companies in India, in accordance with the terms of the relevant agreements entered into with these companies. The company has registered its products in various countries which are marketed through supply, distribution and other arrangements with various dealers / distributors.

The company’s manufacturing facilities are located at Changodar, Ahmedabad, Gujarat. Its facilities have been approved by various international regulatory authorities such as BVQI, WHO, GM:P, CGMP and National Drug Authority of various countries including Nigeria, Ethopia, Ghana, Bolivia, Yemen and Philippines, Uganda, Ivory Coast, etc.

Business area of the company

The company is an Indian pharmaceutical company engaged in the manufacturing and marketing of its own pharmaceutical formulations for domestic and international markets. Its Product domestic sales are generally exported by third party. It also undertakes contract manufacturing of formulations for pharmaceutical companies based in India. It manufactures and markets pharmaceutical formulations relating to analgesics, antielminthics, anti coagulants, anti malarial, anti spasmodics, antianemics, antibiotics, anti-emetics, anti-histamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.

 

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-3.00%
1 Week
+3.63%
1 Month
+8.25%
3 Month
+33.98%
6 Month
+81.26%
1 Year
+227.80%
2 Year
+223.52%
5 Year
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 10.12 13.74 14.46 13.20 14.56 12.83 9.27 11.29 12.57
Return on Capital Employed (%) 12.16 13.68 14.87 13.89 15.29 16.11 14.17 15.45 16.02
Return on Assets (%) 1.95 2.86 3.42 3.58 4.60 5.55 5.03 7.50 9.06

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 11 12 14 15 17 36 51 72 81
Non Curr. Liab. 29 26 24 25 22 22 17 12 20
Curr. Liab. 11 12 15 10 12 13 13 14 14
Minority Int.
Equity & Liab. 51 50 52 50 51 71 81 97 115
Non Curr. Assets 37 38 38 36 38 49 54 77 93
Curr. Assets 14 12 14 14 14 21 27 20 22
Misc. Exp. not W/O
Total Assets 51 50 52 50 51 71 81 97 115

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 16 22 30 35 41 44 53 68 83
Other Income 0 0 0 0 0 1 1 1 2
Total Income 16 22 30 35 41 45 54 69 85
Total Expenditure -9 -14 -22 -27 -33 -34 -41 -51 -63
PBIDT 7 8 8 8 9 11 13 18 22
Interest -4 -4 -4 -3 -3 -3 -3 -2 -2
Depreciation -2 -2 -2 -3 -3 -3 -4 -6 -7
Taxation 0 0 0 -1 -1 -1 -2 -3 -3
Exceptional Items
PAT 1 1 2 2 2 3 4 7 10

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 11 7 9 4 9 9 5 16 10
Cash Fr. Inv. -4 -3 -3 -1 -4 -4 -8 -25 -14
Cash Fr. Finan. -4 -7 -6 -3 -6 -6 -13 9 3
Net Change 3 -4 0 1 -1 -1 -16 0
Cash & Cash Eqvt 4 0 0 1 0 0 -16 0 0

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 71.99 71.99 72.67 72.88 72.88 72.55 72.88 74.02 67.54
Public 28.01 28.01 27.33 27.11 27.12 27.45 27.12 25.97 32.46
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Thu, 05 Aug 2021
Copy of Newspaper Publication
Sakar Healthcare Limited has informed the Exchange about Copy of Newspaper Publication addressed to the Shareholders with respect to the 17th Annual General Meeting.
Tue, 27 Jul 2021
Book Closure
Sakar Healthcare Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 18-Sep-2021 to 24-Sep-2021 for the purpose of 17th Annual General Meeting.
Tue, 27 Jul 2021
Outcome of Board Meeting
Sakar Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on July 26, 2021.

Technical Scans View Details

Thu, 05 Aug 2021
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
CCI Bearish CCI Bearish
William %R Trending Down William %R Trending Down
Wed, 04 Aug 2021
Close Within 52 Week High Zone Close Within 52 Week High Zone

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 188,551.74 785.85 +0.0%
Divi's Laboratories Ltd. 130,702.13 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. 79,575.04 4,783.30 +0.2%
Cipla Ltd. 76,243.85 945.20 +0.6%
Cadila Healthcare Ltd. 59,868.47 584.80 -0.5%
Piramal Enterprises Ltd. 59,065.41 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. 58,599.44 4,075.50 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 31.41 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 65.87 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 45.80 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 31.70 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 28.06 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 44.33 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 389.73 4,075.50 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 3.94 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 14.06 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 4.45 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 4.17 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 4.61 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 1.73 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.75 4,075.50 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 0.10 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 1.16 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,075.50 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 14.13 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 3.33 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,075.50 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 32.07 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 17.85 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 10.03 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,075.50 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 19,159.59 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 12,809.35 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,075.50 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 2,401.30 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 1,074.43 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,075.50 +0.2%